The central nervous system (CNS) is arguably one of the most complex systems in the universe. To understand the CNS, scientists have investigated a variety of molecules, including proteins, lipids, and various small molecules. However, one large class of molecules, noncoding RNAs (ncRNAs), has been relatively unexplored. ncRNAs function directly as structural, catalytic, or regulatory molecules rather than serving as templates for protein synthesis. The increasing variety of ncRNAs being identified in the CNS suggests a strong connection between the biogenesis, dynamics of action, and combinatorial regulatory potential of ncRNAs and the complexity of the CNS. In this review, we give an overview of the diversity and abundance of ncRNAs before delving into specific examples that illustrate their importance in the CNS. In particular, we cover recent evidence for the roles of microRNAs, small nucleolar RNAs, retrotransposons, the NRSE small modulatory RNA, and BC1/BC200 in the CNS. Finally, we speculate why ncRNAs are well adapted to improving organism-environment interactions.
INTRODUCTION
In 1961, Brenner, Jacob, and Meselson obtained experimental evidence for the existence of messenger RNAs (mRNAs), which serve as unstable templates for protein synthesis (Brenner et al. 1961) . Information transfer from mRNAs to proteins is facilitated by two classes of noncoding RNA (ncRNAs), the ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs). Several abundant small nuclear RNAs (snRNAs) were also isolated biochemically and were later recognized as components of the spliceosome, involved in pre-mRNA splicing (Lerner & Steitz 1981 , Zieve 1981 . Thus, with mRNAs serving as templates, and rRNAs, tRNAs, and snRNAs as accessory components, investigators thought the role of RNAs was limited primarily to protein synthesis. Our view of the functions of RNAs has changed dramatically in the past two decades with the discovery of an extremely diverse compilation of ncRNAs, some of which are solitary but interesting cases and others of which are blooming into large families ( Table 1) . Their sizes range from 21 nucleotides (nt), as in the case of mature microRNAs (miRNAs), to more than 100,000 nt, such as the Air (antisense to Ig f 2r) RNA (Lyle et al. 2000) . They can function through a dazzling repertoire of mechanisms and are probably involved in every aspect of biological processes (Eddy 2001 , Mattick & Makunin 2005 , Storz 2002 , Storz et al. 2005 .
A large number of ncRNAs guide protein apparatus to specific DNA or RNA sequences through base-pairing, with the obvious advantage that a very short RNA can provide exquisite sequence specificity, and only small numbers of shared proteins are required to execute complicated catalytic activities. Examples include the small nucleolar RNAs (snoRNAs), which guide site-specific RNA modifications; the miRNAs, which posttranscriptionally repress gene expression; and the rasiRNAs (repeat associated small interfering RNAs), which direct heterochromatin formation at centromeres (Zamore & Haley 2005) . Also by base-pairing, some ncRNAs serve as templates for DNA synthesis by reverse transcriptases, such as the telomerase RNA and, in a broad sense, retrotransposon RNAs. RNA molecules can form stable secondary and tertiary structures and can interact with proteins via a variety of interfaces. Many ncRNAs, such as the spliceosomal snRNAs and the signal recognition particle (SRP) RNA (Doudna & Batey 2004 , Patel & Steitz 2003 , Walter & Blobel 1982 , serve as key scaffolds in ribonucleoprotein (RNP) complexes, whereas most ncRNAs associate with proteins and contribute to the assembly of RNP complexes. In addition to being inert structural components within RNP complexes, some ncRNAs, such as the ribonuclease P RNA (Guerrier-Takada et al. 1983) , have catalytic activities (Fedor & Williamson 2005) , whereas others can regulate the activities of their protein partners. Examples of the latter include the NRSE small modulatory RNA, which converts the NRSF/REST transcription factor from a repressor to an activator (Kuwabara et al. 2004) , and the 7SK RNA, which inhibits the activity of the transcription elongation factor P-TEFb via another protein called HEXIM1/MAQ1 (Michels et al. 2004 ).
How these RNAs modify the activities of their protein partners is still being actively investigated. Some ncRNAs can exert their effects over a long distance, usually on chromosomes, and the mechanism probably involves other processes besides base-pairing. For instance, X chromosome inactivation is initiated by the XIST (X inactive specific transcript) RNA, which spreads in cis along the X chromosome and presumably recruits chromosomal silencing factors onto that chromosome (Penny et al. 1996) . How XIST RNA "spreads" and how it "recruits" silencing factors are still unknown. Some ncRNAs may even function in a sequence-independent manner; by virtue of being synthesized, cis-natural antisense transcripts could interfere with the transcription of the genes located on the opposite strand (Lavorgna et al. 2004) . Considering the fact that the majority of ncRNAs have only recently been identified, they likely act through many other mechanisms.
GENOME-WIDE TRANSCRIPTIONAL STUDIES AND COMPARATIVE GENOMICS
Evidence from recent studies of genomewide transcription suggests that more of the genome is transcribed than is represented by current annotations, and much of it is noncoding. Full-length cDNA sequencing of human cDNA clones suggests that half the transcripts are noncoding (Ota et al. 2004) . Even for Escherichia coli, genome-tiling microarrays at regular intervals, unbiased to predicted exon locations, have revealed a large amount of antisense and intergenic transcription (Selinger et al. 2000) . The use of such genome-tiling arrays in human chromosomes 20 and 22 (Schadt et al. 2004) , in Arabidopsis (Stolc et al. 2005; Yamada et al. 2003) , and in Drosophila melanogaster (Stolc et al. 2004 ) has all suggested that the levels of transcriptional activity far exceed the predicted coding regions in the various genomes. A study at the smallest resolution thus far, at 5 nt, mapped transcriptional activity across 10 human chromoGenome-tiling microarray: type of microarray in which all nonrepetitive DNA sequences comprising a chromosome or locus are represented at regular intervals
GENOME-TILING MICROARRAYS
DNA microarrays, commonly used to measure global mRNA expression levels, are important and useful tools for highthroughput studies of gene expression and regulation. The recent development of genome-tiling microarrays has expanded microarray applications. Probes on most traditional gene expression microarrays (e.g., Affymetrix GeneChips) are chosen based on the coding sequences of annotated genes. In contrast, probes on genome-tiling microarrays are designed to cover the entire nonrepetitive portions of a genome, chromosome, or genomic locus at regularly spaced intervals. Because genome-tiling microarrays represent an entire genomic region, they enable the discovery of novel transcripts as well as the delineation of transcript boundaries and splice junctions. When combined with other experimental protocols, genome-tiling microarrays can be utilized to identify chromatin modification sites, transcription regulatory elements, and chromosome replication origins. For example, in conjunction with chromatin immunoprecipitation, a procedure involving in situ fixation of protein-DNA interactions followed by immunoprecipitation with antibodies specific to the protein of interest, tiling arrays allow unbiased mapping of transcription factor-binding sites. For more information on genome-tiling microarrays, please refer to an excellent review by Bertone et al. (2005) . somes and revealed that an average of 10% of the genome corresponded to polyadenylated transcripts, of which the majority did not match known genes (Cheng et al. 2005) . More recent data from the FANTOM 3 consortium have opined that 62% of the mouse genome is transcribed, with ∼90,000 independent ncRNA transcripts (half of the total number of transcripts observed) (Carninci et al. 2005) . Furthermore, almost three quarters of the observed transcriptional units overlap another transcript from the opposite strand (Carninci et al. 2005 , Katayama et al. 2005 .
Comparative genome analysis is useful for determining whether a predicted locus (from tiling array data, for example) is a noncoding or protein-coding locus, as well as for identifying particular classes of new ncRNAs. (Sleutels et al. 2002) . However, no human Air transcripts have been reported so far. Accordingly, the Igf2r locus is not imprinted in the primate lineage (Killian et al. 2001) . With the myriad of ncRNAs discovered, it is still debatable whether they are functional entities or merely transcriptional background. Evidence supporting the notion that at least some of them are functional comes from the demonstration that a subset of the ncRNAs transcribed from human chromosome 21 are conserved in the mouse (Dermitzakis et al. 2002) . Experimentally, chromatin immunoprecipitation of transcription factors combined with genome-tiling microarray has also revealed that comparable numbers of binding sites are located near noncoding and coding genes, suggesting that many ncRNAs are biologically regulated (Cawley et al. 2004 ). In addition, ∼20% of the studied ncRNAs are regulated in response to retinoic acid (Cawley et al. 2004) . Recently, as an initial approach to systematically probing the functions of ncRNAs, a library of small interfering RNAs (siRNAs) designed against 512 evolutionarily conserved ncRNAs was developed. In a cellbased assay utilizing this library, investigators showed a ncRNA christened NRON (noncoding repressor of NFAT) to be a repressor of the transcription factor NFAT (Willingham et al. 2005) .
MicroRNAs
MicroRNAs (miRNAs) are endogenous ∼21-nt single-stranded RNAs processed by Dicer, a double-stranded RNA (dsRNA)-specific endonuclease, from one arm of ∼70-nt stemloop precursors (pre-miRNAs) (Ambros et al. 2003) . Pre-miRNAs, in turn, are excised from longer primary transcripts (pri-miRNAs) by another dsRNA-specific endonuclease named Drosha. miRNAs function as negative regulators of gene expression by base-pairing with, in many cases, the 3 -untranslated region (3 -UTR) of target mRNAs in the form of ribonucleoprotein complexes known as RNAinduced silencing complexes (RISCs). Although plant miRNAs are generally perfectly complementary to target mRNAs and trigger mRNA degradation, most animal miRNAs form imperfect base-pairs with their targets, with nucleotides 2-7 (the "seed" region) of a miRNA being most critical for target recognition. Investigators first thought that miRNAs with partial complementarity to their targets affected only protein synthesis but not mRNA stability, and that the effect took place after translational initiation (Olsen & Ambros 1999) . Recent data showed that mammalian let-7 miRNA inhibited translational initiation (Pillai et al. 2005) , whereas C. elegans let-7 and lin-4 miRNAs triggered the destruction of their targets (Bagga et al. 2005) . It is possible that different miRNAs, in different organisms and/or in combination with different protein apparatus, can function through diverse mechanisms (Figure 1 ). More than 200 miRNAs have been identified per species A model for the biogenesis and mechanism of action of miRNAs. miRNA genes are transcribed by RNA polymerase II to generate the primary miRNA transcripts (pri-miRNAs), which are processed into the ∼70-nt hairpin-structured miRNA precursors (pre-miRNAs) by Drosha in the nucleus. After being transported to the cytoplasm by exportin 5, pre-miRNAs are further processed by Dicer to generate the miRNA:miRNA * duplexes. Upon unwinding, one strand of the duplex is preferentially integrated into the RNA-induced silencing complex (RISC) and directs it to mRNA targets via base-pairing. RISCs may localize bound mRNAs to processing bodies (P-bodies), specialized cytoplasmic compartments of mRNA turnover. Sequestration of mRNAs inside P-bodies, where there are no ribosomes, may result in translational repression. Some mRNAs may be degraded inside P-bodies by deadenylation-mediated mRNA decay. RISCs, in conjunction with tristetraprolin (TTP), may deliver mRNAs with AU-rich elements (AREs) to exosomes for destruction. Still other unknown mechanisms may account for the degradation or translational repression of RISC-loaded mRNAs.
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in higher organisms. Because the interaction between a miRNA and its target requires only partial complementarity, one miRNA could regulate hundreds of mRNAs. Lewis et al. (2005) proposed that more than onethird of all human genes may be regulated by miRNAs. For more in-depth discussions on the biogenesis, mechanism of action, and functions of miRNAs, please refer to the following reviews and the references therein . We focus here on miRNAs in the nervous system. The small size of miRNAs makes them difficult to detect by in situ hybridization. Northern blotting and microarrays have been the methods of choice to study the expression patterns of miRNAs. Many mammalian miRNAs are expressed in a temporal and/or tissue-specific manner. The brain, in particular, hosts a diverse collection of miRNAs; approximately 70% of experimentally detectable miRNAs are expressed in the brain, and among those with tissuespecific/enriched expression patterns, half are brain-specific/enriched (Babak et al. 2004 , Barad et al. 2004 , Miska et al. 2004 , Sempere et al. 2004 , Thomson et al. 2004 ) ( Table 2) . During brain development, the expression levels of some miRNAs change dynamically (Krichevsky et al. 2003 , Miska et al. 2004 , Smirnova et al. 2005 . miRNA expression profiles have also been examined in in vitro systems such as primary neurons (Kim et al. 2004 ) and P19 embryonic carcinoma cells; primary neurons in culture follow a series of morphological events that lead to mature, differentiated neurons, whereas P19 cells can be induced to differentiate to neurons by retinoic acid (RA). Upon RA treatment, numerous miRNAs are induced in P19 cells, including both brain-specific/enriched ones and those not enriched in the brain (Sempere et al. 2004 ). However, some brain-expressed miRNAs (e.g., miR-29 and -128) are not detected in neurons derived from RA-treated P19 cells. These miRNAs are probably present primarily in non-neuronal cell types such as glia or are present in neuronal subtypes not represented in neurons derived from P19 cells. Some miRNAs indeed show lineagespecific expressions, as detected in primary cultures of neurons and astrocytes (Smirnova et al. 2005) .
Functional studies of miRNAs in the nervous system are still sparse. In C. elegans, two miRNAs, miR-273 and lsy-6, and their transcription factor targets form a complex generegulatory network that not only controls the cell fate decision between two taste receptor neurons but also assures the stability and irreversibility of the terminal differentiated state ( Johnston et al. 2005 , Johnston & Hobert 2003 . Dicer-deficient zebrafish, which lack all mature miRNAs, showed abnormal morphogenesis including defects in neural development (Giraldez et al. 2005) . Formations of brain ventricles, midbrain-hindbrain boundary, and constrictions in the hindbrain were severely reduced. Some trigeminal sensory neurons were mispositioned. Axon fasciculation was reduced in some regions. Touchinduced escape behavior was severely diminished. Notably, the various defects in neural development were substantially rescued by the injection of a single family of miRNA, miR-430, which is ubiquitously expressed during early stages of development. The zebrafish miR-430 family of miRNAs share the highest sequence homology with the mammalian miR-17 family. However, mature miRNAs from these two families are derived from different arms of their precursors, suggesting convergent rather than divergent evolution of these two families. Instead, the miR-430 miRNAs may share evolutionary origins with some of the miRNAs expressed specifically in mammalian embryonic stem cells, including miR-302 and miR-372, which have the same seed nucleotides and are derived from the same arm of the precursors. It remains to be determined if the function of miR-430 is conserved in mammals. Meanwhile, it is rather Table 2 A summary of expression-profiling studies of neural-related miRNAs. Owing to the differences in the expression levels of individual miRNAs, the detection methods, and the numbers of tissue types examined, the expression-profiling results from various labs are not always the same.
Brain-specific/enriched miRNAs (Babak et al. 2004 , Barad et al. 2004 , Kim et al. 2004 , Lagos-Quintana et al. 2002 , Miska et al. 2004 , Sempere et al. 2004 , Thomson et al. 2004 Brain-specific miR-9, -9 * , -124, -128 Brain-enriched miR-125 "Might be" brain-specific/enriched (shown by some labs but not by others) miR-7, -34, -127, -129 * , -132, -135, -136, -138, -139, -149, -153, -154, -218, -219, -222, -323, -326, -329, -344, etc. miRNAs with dynamic expression levels during brain development (Krichevsky et al. 2003 , Miska et al. 2004 , Smirnova et al. 2005 Initially expressed at low levels, increase continuously during embryonic development, gradually decline during postnatal periods miR-9, -9 * , -125b, -181a
Initially expressed at low levels, increase continuously during embryonic development, plateau around birth miR-124a, -130b
Initially expressed at low levels, increase continuously until adult miR-103, -128 Highest expression at (rat) embryonic day 12 (E12, the earliest time point examined), decrease from E12 to adult miR-17, -18, -19, -20, -92, -199a Start surprising and puzzling that many aspects of early embryonic development in zebrafish apparently do not require miRNAs, as early patterning and fate specification were largely unaffected by Dicer deletion. In comparison, much more severe defects were observed in Dicer-deficient mice, which died very early in development (around embryonic day 7.5) and were depleted of pluripotent stem cells (Bernstein et al. 2003) . miR-124 is the most abundant miRNA in the adult mammalian brain, accounting for 25%-48% of all brain miRNAs (LagosQuintana et al. 2002) . Conserved sequences complementary to the seed region of miR-124 are prevalent in the 3 -UTRs of mammalian transcripts, with more than 1100 genes being predicted to be putative targets of miR-124 (Lewis et al. 2005) . When miR-124 was transfected into HeLa cells, 174 annotated genes were downregulated (Lim et al. 2005) . These genes are significantly enriched for genes expressed at lower levels in the brain relative to other tissues. Thus, in a sense, expressing this brain-specific miRNA in HeLa cells shifted the gene expression profile toward that of the brain. In comparison, transfecting miR-1 shifted the profile toward that of the heart and skeletal muscle, where miR-1 is preferentially expressed. Furthermore, 76% of the genes downregulated by miR-124 contain in their 3 -UTRs a hexamer that matches the seed region of miR-124, which suggests that these genes are direct targets of miR-124. This study provided the first experimental confirmation that a single miRNA could regulate a large number of mRNAs. Lossand gain-of-function studies in vivo are required to tell whether miR-124 is required to maintain the gene expression profile in the brain or can actually promote neuronal differentiation.
The miRNA pathway has recently been linked to fragile X mental retardation protein (FMRP), a protein that is absent or mutated in patients with fragile X syndrome. FMRP is an RNA-binding protein that associates with mRNAs and functions as a translational repressor (Zhang & Broadie 2005) . Mammalian FMRP interacted with miRNAs and Argonaute 2, the key protein component of RISCs. Genetic studies in Drosophila further demonstrated that FMRP functioning required AGO1 (the Drosophila ortholog of Argonaute 2); reduction of AGO1 suppressed neuronal apoptosis caused by the overexpression of dFmr1 (Drosophila fragile X mental retardation 1 gene), whereas AGO1 and dFmr1 heterozygotes showed more severe synaptic overgrowth phenotype than that found in dFmr1 null mutants ( Jin et al. 2004 ). An analysis of 397 FMRP-associated mRNAs identified in several genome-wide approaches revealed that 74% were predicted miRNA targets, much higher than one would expect from a randomly chosen set of mRNAs (15% according to the algorithm used) (John et al. 2004 ). Although it is not clear whether FMRP first binds to its mRNA targets, recruiting miRNAs and RISCs, or vice versa, the combined action of FMRP and miRNAs will presumably increase the specificity of target recognition. The link between FMRP and the miRNA pathway will provide more insights not only into the pathogenesis of fragile X syndrome but also into the mechanisms of miRNA-mediated gene regulation.
SMALL NUCLEOLAR RNAs
Small nucleolar RNAs (snoRNAs) reside in the nucleolus and guide site-specific modifications of nucleotides in target RNAs (Kiss 2001) . Two types of modifications, 2 -Omethylation and pseudouridylation, are directed by two classes of snoRNAs named box C/D and box H/ACA snoRNAs, respectively (Figure 2A ) . Two sets of proteins associate with these two classes of snoRNAs in the form of ribonucleoprotein particles (snoRNPs). Within each snoRNP, one of the protein components carries the enzymatic activity, whereas the snoRNA base-pairs with the target RNA via its antisense elements. Targets of snoRNA-directed modifications are mostly housekeeping RNAs such as rRNAs, tRNAs, and snRNAs.
Among the more than 300 snoRNAs, most are ubiquitously expressed, consistent with their function in modifying housekeeping RNAs. Seven brain-specific snoRNAs have been identified so far, all of them being orphan snoRNAs with unknown targets (Cavaille et al. 2000 , Huttenhofer et al. 2001 . Their expression may be further regulated by environmental and/or physiological factors. For instance, downregulation of MBII-48 (MB stands for mouse brain and II for box C/D class) and upregulation of MBII-52 were observed specifically during the early, but not late, phase of memory consolidation after contextual fear conditioning, which suggests that these snoRNAs may have a role in higher brain function (Rogelj et al. 2003) . Genes encoding three of the brain-specific snoRNAs (HBII-13, HBII-52, and HBII-85), among other genes in the human chromosome region 15q11-13, are deleted in patients with Prader-Willi syndrome (PWS), a neurobehavioral disorder characterized by infantile hypotonia, hypogonadism, neonatal feeding difficulty followed by hyperphagia, and mental retardation. Mouse models of PWS also show neonatal lethality, possibly because of feeding difficulty. Indirect evidence suggests that the lack of the MBII-85 gene is the most likely cause of neonatal lethality in PWS mice (Ding et al. 2005) .
One of the brain-specific snoRNAs, MBII-52, harbors an 18-nt conserved sequence complementary to a segment of serotonin receptor 2C (5-HT 2C ) mRNA (Cavaille et al. 2000 , Filipowicz 2000 (Figure 2B ). This segment is located within the alternatively spliced exon
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ANRV278-NE29-03 Vb. Two isoforms of serotonin receptor 2C can be generated via alternative splicing, a truncated and inactive one that includes exon Va only and a functional one that contains both Va and Vb. The alternative exon Vb has five adenosine-to-inosine (A-to-I) editing sites. RNA editing of exon Vb produces at least two effects: It promotes the inclusion of exon Vb in the mature 5-HT 2C mRNA but at the same time changes the amino acid sequence of the intracellular loop, resulting in decreased receptor efficacy (Wang et al. 2000) . The nucleotide potentially targeted for 2 -O-methylation by MBII-52 corresponds precisely to one of the editing sites, the C-site, that is important in regulating serotonergic signaling (Wang et al. 2000) . 2 -O-methylation of adenosine should severely interfere with its deamination to inosine (YiBrunozzi et al. 1999) . Indeed, coexpression of MBII-52 in NIH-3T3 cells with the A-to-I editing enzyme adenosine deaminase ADAR2 and a 5-HT 2C pre-mRNA driven by an RNA polymerase I (Pol I) promoter specifically reduced the editing at C-site (Vitali et al. 2005) . Two critical points are still missing in this study. First, the authors were not able to show directly that 5-HT 2C mRNA was a substrate of MBII-52-guided methylation. Second, in NIH-3T3 cells, MBII-52 affected the editing of 5-HT 2C pre-mRNA only when the premRNA was transcribed within the nucleolus by Pol I but not when it was transcribed in the nucleoplasm by Pol II. Under certain circumstances, 5-HT 2C pre-mRNA could perhaps be located transiently to the nucleolus. Or more likely, MBII-52 may sometimes function in the nucleoplasm, considering that is where snoRNAs are generated (from introns of pre-mRNAs by splicing) (Kiss 2001). Recently, Kishore & Stamm (2005) found that MBII-52 regulated the alternative splicing of 5-HT 2C pre-mRNA by a mechanism that is independent of RNA editing or even 2 -Omethylation. The authors noticed that two splicing silencers resided within the MBII-52 complementary region in exon Vb. Coexpression of MBII-52 with a 5-HT 2C splicing reporter minigene led to increased inclusion of exon Vb, likely through masking the splicing silencers. Remarkably, the authors showed that in PWS patients, who lacked HBII-52 because of genomic deletions (see above), the isoforms of 5-HT 2C mRNA with unedited sequences in exon Vb were abnormally low. Since these receptor isoforms exhibit the strongest response to serotonin, this finding suggests that defects in serotonergic system may contribute to PWS. In summary, these studies raise the fascinating possibility that certain snoRNAs can target mRNAs and affect processes including RNA editing and alternative splicing. These novel functions of snoRNAs would be particularly significant in the nervous system, where RNA editing and alternative splicing are most abundant (Lipscombe 2005 , Paul & Bass 1998 .
RETROTRANSPOSONS
Retrotransposons and their recognizable remnants constitute a large fraction of the mammalian genome. Retrotransposons are transcribed into RNAs and then reverse transcribed and reintegrated into the genome, thereby duplicating the original element independent of genome replication. The process of mobilizing a retrotransposon is called retrotransposition, and it involves transcription, RNA processing, translation, and finally integration of the reverse-transcribed DNA into a new location in the genome. Thus, retrotransposons can greatly increase their copy number in the genome. Almost all the repeated DNA sequences in mammalian genomes were produced by retrotransposons. They may have been early participants in genome formation. Since then, they have been shaping genomes during evolution through a large spectrum of creative genetic tricks, including insertions, deletions, rearrangements, and gene duplications. Currently, most retrotransposons are dormant owing to the high number of mutations in their sequences. However, modern mammalian genomes still carry some active ANRV278-NE29-03 ARI 15 February 2006 19:38 autonomous transposable elements that can mobilize themselves with their encoded proteins. Perhaps the most active of them are LINE-1 (long interspersed nucleotide element-1, or L1) elements. SINEs (short interspersed nucleotide elements) are usually ∼300 base-pairs (bp) long and resemble L1s in the sense that they lack long terminal repeats (LTRs) and introns, terminate in a poly(A) tail, and are flanked by target-site duplications. However, they are classified as nonautonomous retrotransposons because they do not encode proteins necessary for their mobility. Alu elements are a class of SINEs derived from 7SL RNA, which consist of a 280-nt noncoding sequence (Schmid 1998) . Alus represent ∼10% of the human genome and have accounted for more than 20 cases of human genetic diseases (Ostertag & Kazazian 2001a) . L1s are the dominant family of retrotransposons in mammals. L1 elements represent ∼17% of the human genome, with an average of 80-100 active L1s in the human diploid genome. Recently evolved L1s are polymorphic, allowing individual variations in retrotransposition capability (Lutz et al. 2003) .
Full-length active L1 elements are ∼6 kb long, consisting of a 5 -UTR that has promoter activity, two open reading frames (ORFs)-one encoding a nucleic acid binding protein and the other an endonuclease and reverse transcriptase (RT)-a 3 -UTR, and a poly(A) tail. Genomic L1 insertions are often 5 truncated (and thus immobile), which is probably caused by the low processivity of the L1 RT. The L1 retrotransposition takes place in the nucleus through a mechanism called target primed reverse transcription (Cost et al. 2002 , Ostertag & Kazazian 2001b . In this mechanism, the L1 endonuclease nicks the genomic DNA, exposing a 3 hydroxyl group, which is used as the primer for the L1 RT to initiate the synthesis of L1 cDNA, with the L1 RNA serving as the template. The L1 endonuclease is not highly sequence specific, preferentially cleaving a short consensus DNA sequence (5 -TTTT/A-3 , in which "/" LINE-1 or L1: long interspersed nucleotide element-1 RT: reverse transcriptase indicates the scissile phosphodiester bond); thus it could cut a very large number of sites in the genome (Cost et al. 2001 , Cost & Boeke 1998 . Moreover, L1 insertions can occur at sites of DNA double-strand breaks by an endonuclease-independent pathway (Morrish et al. 2002) . L1 proteins have strong cis preference, i.e., they prefer to act on the RNA that encodes them (Wei et al. 2001) . Nonetheless, L1 elements can also retrotranspose nonautonomous sequences in trans, such as SINEs or Alus (Kajikawa & Okada 2002) . L1 elements can generate pseudogenes (Esnault et al. 2000) , which arise by reverse transcription of cellular mRNAs followed by integration of the resulting cDNAs into the genome. Through this mechanism, virtually any RNA can be retrotransposed.
Several studies have indicated that L1 retrotransposition can occur in germ cells, early embryonic cells (Ostertag et al. 2002 , Prak et al. 2003 , and a variety of transformed or immortalized cell lines (Han et al. 2004 , Moran et al. 1996 , Morrish et al. 2002 . The lack of examples of natural L1 somatic insertions suggests that retrotransposition is likely to be restricted to germ cells and early embryonic cells and that L1 elements are probably silenced in most somatic tissues. However, a major problem in the analysis of retrotransposition events is that the mobility of transposable elements is detected primarily through the phenotypic mutations that occasionally result from transposon insertions into new loci, and therefore only a fraction of the transposition events are scored. There is only one example of a bona fide somatic L1 insertional event in vivo, where L1 is inserted into the Adenomatous polyposis coli gene in a case of colorectal tumor (Miki et al. 1992 ). Yet both the timing of the event and the initial cell type that harbored it remain unclear.
Transcripts from several kinds of retrotransposons have been detected in brain tissues of mammalian species, including humans (Frank et al. 2005 , Karlsson et al. 2001 , Yokota et al. 1989 syndromes also showed expression of endogenous retroviruses (Frank et al. 2005 , Karlsson et al. 2001 , Kim et al. 1999 , Nakamura et al. 2003 , Yolken et al. 2000 . However, no evidence for mobilization has been described until recently. By taking advantage of an engineered L1 retrotransposon, we have shown that L1 elements can retrotranspose specifically in neuronal progenitor cells (NPCs) in culture and in transgenic mouse brains (Muotri et al. 2005) . In this assay, an active L1 element was tagged with an enhanced green fluorescent protein (EGFP) indicator cassette, in which EGFP will be expressed only after L1 transcription, splicing, reverse transcription, and final integration into the genomic DNA (Ostertag et al. 2000) . By characterizing cells that express the EGFP marker, one can study the mechanism of L1 mobilization. The molecular mechanism that regulates L1 activation in NPCs is not completely understood. Preliminary results suggest that a key component is the transcription factor Sox2, which binds to the 5 promoter region of L1 elements. Sox2, a member of the SRY family of transcription factors, is expressed in germ cells as well as in embryonic and adult neural stem cells (D'Amour & Gage 2003) . In neural stem cells, Sox2 represses L1 transcription together with several chromatin-remodeling factors, including histone deacetylase 1 (HDAC1). Upon neuronal differentiation, Sox2 expression is diminished. Possibly with the help of other unidentified neuronal specific factors, the chromatin structure of the L1 promoter is switched from a transcriptional silenced status to an active one, allowing the stimulation of L1 transcription. Even with a small set of samples, the characterization of L1 integrations in mouse brains and cultured NPCs reveals that L1 has a tendency to insert into genes expressed in neurons, such as the insertion observed in the 5 -UTR of the Psd-93 gene (Muotri et al. 2005) . In contrast, L1 retrotranspositions in germ cells seem to avoid coding regions (Kazazian 2001). We currently do not know why there is such a difference between the two systems. One should keep in mind that the L1 retrotransposition assay reflects the activity of a single L1 element and relies on the expression of the EGFP indicator cassette for an event to be scored, therefore missing EGFP-truncated events and events mediated by L1 in trans. Accordingly, more endogenous L1 elements may be activated, and every developing neuron may have at least one L1-related insertion. If some of these insertions directly affect the expression of neuronal genes, then there is a great chance that L1 elements can profoundly affect the development of the nervous system (Figure 3) .
NRSE SMALL MODULATORY RNA
Neurons differ from any other type of cells by containing a specific set of proteins that have critical functions in neurons but must not be expressed in non-neuronal cells. A large number of genes important for neuron functioning contain a specific sequence in their promoter regions. The sequence is about 20-23 bp in length and is termed the neuron-restrictive silencer element/repressor element 1 (NRSE/RE1), which is recognized by the neuron-restrictive silencing factor/repressor element 1 silencing transcription factor (NRSF/REST). Through the specific binding between the NRSF/REST transcription factor and NRSE/RE1 element, expressions of diverse neuronal genes are regulated at their transcriptional levels (Bruce et al. 2004) . When NRSF/REST binds to cofactor proteins that work as negative transcriptional regulators, neuronal genes with NRSE/RE1 sequences are silenced (Andres et al. 1999 , Grimes et al. 2000 , Huang et al. 1999 , Lunyak et al. 2002 . NRSF/REST has two repressor domains that differentially interact with cofactor proteins, including Co-REST, mSin3A, and SCPs [small CTD (RNA polymerase II carboxyl-terminal domain) phosphatases], which in turn recruit HDACs, histone methyltransferases, and LSD1 (lysine specific demethylase 1)-containing A model for L1 retrotransposition in neuronal precursor cells. Full-length L1 elements contain a 5 -untranslated region (UTR) with internal promoter activity, two open reading frames (ORF1 and ORF2), a 3 -UTR, and a poly(A) tail. The expression of L1 is repressed in neural stem cells by the direct binding of Sox2 to the 5 -UTR and the closed chromatin status in that region. During neuronal differentiation, the downregulation of Sox2, epigenetic modifications at the L1 5 -UTR, and possibly the binding of other neuronal transcription factors lead to the activation of L1 expression. L1 transcripts are translated into ORF1 and ORF2 proteins in the cytoplasm, where they preferentially assemble with their template RNAs (cis preference) into ribonucleoprotein (RNP) complexes. L1 proteins can also hijack other RNAs, such as Alus, SINEs, or any other mRNAs, albeit at a lower frequency. Once back into the nucleus, the endonuclease (EN) domain of ORF2 scans the genomic DNA for target sequences. In neuronal precursor cells, target selections are biased toward neuronal genes being transcribed at that moment. A nick in the target sequence exposes the 3 -OH group that is used by the reverse transcriptase (RT) of ORF2 to prime the reverse transcription of L1 RNA, a process called target primed reverse transcription (TPRT). After reverse transcription and second strand synthesis, the new copy, often 5 truncated and flanked by target site duplications (TSD), is integrated into the genome. Both L1 and L1-mediated integrations have the potential to alter the expression of nearby genes.
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ANRV278-NE29-03 complexes to NRSE/RE1 sites (Ballas et al. 2005 , Lunyak et al. 2002 , Shi et al. 2004 , Yeo et al. 2005 . Transcriptional silencing of neuronal genes that contain the NRSE/RE1 sequence was observed in non-neuronal cells during development and in embryonic stem cells (Ballas et al. 2005) . Although the disappearance of NRSF/REST repressor complex in differentiating neurons leads to the expression of NRSE/RE1-containing genes during development, the expression of NRSF/REST has been observed in adult neurons (Calderone et al. 2003 , Kuwabara et al. 2004 , Sun et al. 2005 , Zuccato et al. 2003 .
How could NRSE/RE1-containing neuronal genes, such as those encoding synaptic vesicle proteins, neurotransmitter receptors, and adhesion molecules, be expressed in functional neurons when NRSF/REST is present? One mechanism to cancel the repressor effect of NRSF/REST has been demonstrated by the discovery of a nuclear localized small modulatory RNA (smRNA), which appears transiently at the early period of neuronal differentiation in cultured adult neural stem cells (Kuwabara et al. 2004 ). This double-stranded smRNA is about 20 bp in length, carrying the same sequence as NRSE/RE1 and hence designated as NRSE smRNA. The NRSF/REST transcription factor binds specifically to the NRSE smRNA while remaining associated with NRSE/RE1-containing genes. Binding the NRSE smRNA to NRSF/REST prevents the association of corepressor proteins such as HDACs and methyl-DNA binding proteins and, possibly through additional mechanisms, converts NRSF/REST to a transcriptional activator. After the NRSE smRNA appears, transcriptional activation of NRSE/RE1-containing genes is triggered. This short smRNA thus works as a transcriptional coactivator for a large set of neuronal genes.
BC1/BC200 RNAs
BC1 (brain cytoplasmic RNA 1) and BC200 (brain cytoplasmic RNA 200-nt) RNAs are transcribed by RNA polymerase III (Sutcliffe et al. 1982 , Watson & Sutcliffe 1987 . Both RNAs are recently evolved by separate retrotransposition events. BC1 resulted from retrotransposition of tRNA Ala and is found in all rodent species examined. BC200 arose from a transcribed monomeric Alu element, which in turn was derived from SRP RNA and is restricted to Anthropoidea (Martignetti & Brosius 1993 , Skryabin et al. 1998 ). Although they belong to different evolutionary pedigrees and share little sequence homology, BC1 and BC200 form similar secondary structures (Zalfa et al. 2003) . Thus far, no similar RNA has been identified in other species. Both of these cytoplasmic RNAs are specifically expressed in neurons and are actively transported to dendrites (Tiedge et al. 1993) . In cultured hippocampal neurons, the expression of BC1 is first detected at the onset of synaptogenesis, and the expression level is reversibly regulated by neuronal activity (Muslimov et al. 1998) . BC1-deficient mice were healthy with normal brain morphology and no obvious neurological deficits. Extensive behavioral studies revealed reduced exploration and increased anxiety in mutant animals (Lewejohann et al. 2004 ). Owing to their evolutionary origins, BC1 and BC200 have been subject to speculation that they participate in the regulation of protein synthesis in neuronal dendrites because BC1 arose from a tRNA and BC200 represents the Alu domain of SRP RNA, the domain involved in translation arrest. Both RNAs interacted with poly(A)-binding protein, a regulator of translation initiation (Muddashetty et al. 2002) . BC1 affected translation by inhibiting the formation of the pre-initiation complex, and the inhibitory effect was not restricted to particular mRNAs (Wang et al. 2002) . Zalfa et al. (2003) recently showed that BC1/BC200 not only directly interacted with FMRP but also bound to several FMRP targets via base-pairing, therefore proposing that BC1/BC200 RNAs help define the specificity of FMRP-mediated translational repression (Figure 4) .
Figure 4
A model for the function of BC1/BC200 RNAs in translational regulation. (A) Eukaryotic translation is initiated by the binding of eIF4F, a multisubunit protein complex consisting of eIF4E, eIF4A, and eIF4G, to the 5 cap structure of mRNAs. eIF4F then recruits the pre-initiation complex containing the small (40S) ribosomal subunit, the methionine-loaded initiator tRNA, and other initiation factors. The pre-initiation complex scans the mRNA in a 5 →3 direction until it encounters the initiation codon AUG. Through the eIF4G subunit, eIF4F also interacts with poly(A)-binding protein (PABP), which is required for efficient translation initiation. The BC1/BC200 RNAs may repress translation through two mechanisms. (B) BC1/BC200 can directly interact with FMRP and, via base-pairing, some FMRP target mRNAs. Translational inhibition is executed by FMRP. By bridging FMRP to its mRNA targets, BC1/BC200 may increase the specificity of substrate recognition by FMRP. (C) BC1/BC200 bind to PABP through an adenine-rich region, titrating PABP and possibly other initiation factors away from mRNAs and thus inhibiting translation. The inhibitory effect caused by this mechanism, which does not depend on the direct interaction between BC1/BC200 and affected mRNAs, is not restricted to specific mRNAs.
RNA AND NEUROLOGICAL DISEASES
Recently, investigators have discovered a number of dominant noncoding expansion disorders, including myotonic dystrophy type 1 and 2 (DM1 and DM2), spinocerebellar ataxia 8 (SCA8), SCA10, SCA12, and fragile X tremor ataxia syndrome (FXTAS) (Ranum & Day 2004) . This group of repeat expansion disorders differs from the polyglutamine diseases in that the expanded repeats reside within the noncoding region, either intron or untranslated region, of a gene. The SCA8 gene is likely to encode a noncoding RNA, whereas others are all protein-coding genes. Although the symptoms of DM1 and DM2 are strikingly similar, the host genes for the expanded repeats are unrelated, which is also the case for SCA8, SCA10, and SCA12. Thus these diseases are not likely to be caused by loss-of-functions of host genes, consistent with the dominant nature of these diseases. Substantial evidence indicates that all these disorders are caused by a pathogenic RNA gain-of-function mechanism. While keeping in mind the complexity of these various diseases, a simplified model suggests that the expansion-containing RNAs accumulate inside the cell and form ribonuclear foci. These foci bind and sequester RNA-binding proteins such as splicing factors, which result in aberrant splicing of target genes. As this novel mechanism of "pathogenic RNA" is being recognized, we expect that more diseases will fit into the category of dominant RNA expansion disorders. Interested readers are encouraged to refer to an excellent review on this subject by Ranum & Day (2004) . Most researchers believe that transmissible spongiform encephalopathies are caused by a proteinaceous infectious agent, designated as "prion" (PrP Sc ), that propagates itself by inducing a conformational change in the normal cellular form of the protein, called PrP C (Chien et al. 2004 ). Deleault et al. (2003) recently showed that single-stranded RNA, but not double-stranded RNA, RNA:DNA hybrids, or DNA, could stimulate PrP Sc propagation in brain homogenates. Interestingly, the stimulatory effect was only observed with mammalian RNA but not bacterial or invertebrate RNA. These results raise the possibility that host-encoded stimulatory RNA may be involved in the pathogenesis of prion diseases. However, the same group found later that, in a defined system with purified PrP Sc and PrP C , the stimulatory activity of RNA is no longer species specific. In fact, a number of polyanions, such as DNA and heparin sulfate proteoglycan, can stimulate PrP Sc propagation in the purified system (Deleault et al. 2005) . At present, it is not clear what causes these discrepancies or whether RNA has any role in prion diseases.
CONCLUDING REMARKS
Sequencing and annotation of the human genome has provided estimates of proteincoding gene numbers that are slightly higher than in the nematode C. elegans and less than in the plant Arabidopsis. Wherein lies human complexity? Accumulating evidence suggests that, as organisms become more complex, the amount of noncoding regions in the genome escalates, mostly due to transposable DNA elements, but in part owing also to noncoding RNA genes (Huttenhofer et al. 2005 , Shabalina & Spiridonov 2004 .
On evolutionary time scales, changes that improve the fitness of an organism will be retained. The fitness of organisms can be improved by evolving new genes with functions that differ from already present genes, thereby exploring new areas in the fitness landscape. One way to evolve new genes is by duplication of entire genes, or functional pieces of genes (such as exons encoding modular protein domains), whereby the original gene or exon and its function are preserved and the copy is free to acquire new roles. However, such duplication of genes or exons is not without inherent dangers. If a duplicated gene or exon inserts into a region of function, e.g., a protein-coding sequence, it is likely to have severe effects on the organism. The likelihood of such a situation will decrease if the duplicated pieces are small, such as exons that are usually ∼150-bp long. For example, ion channel genes have duplicated exons that are mutually exclusively spliced, thus enhancing the diversity of channel properties (Copley 2004) . The relatively small sizes of ncRNAs, in comparison to protein-coding genes (∼tens of kilobases), make them preferred candidates for gene duplications; not only are they easier to duplicate intact, they are less likely to disrupt existing genes or other functional regions in the genome. Indeed, many miRNAs can be grouped to families based on sequence similarity, which may be a result of many gene duplication events.
Figure 5
Potential roles of ncRNAs in neuronal differentiation and functioning. miRNAs repress gene expression by binding to the 3 -UTR of mRNAs via imperfect base-pairing. miRNAs have been implicated in the maintenance of pluripotent stem cells and may also have roles in the self-renewal of neural stem cells. In neuronal progenitor cells, L1 retrotransposable elements are expressed and may insert into neuronal genes that are expressed in the same time frame, affecting their expression. In addition, the NRSE smRNA interacts with transcription factor NRSF/REST and activates NRSE/RE1-containing genes, leading to neuronal differentiation. The Lsy-6 miRNA in C. elegans plays a role in cell-fate determination between two taste receptor neurons. Similar mechanisms may be present for other miRNAs in neuronal progenitor cells or in other species. In mature neurons, BC1/BC200 RNAs are transported to dendrites and may regulate dendritic mRNA translation through their interaction with the translational machinery and/or with FMRP. miRNAs also associate with FMRP and may regulate dendritic mRNA expression as well. Both mechanisms are probably involved in synaptic plasticity. The snoRNA MBII-52 may regulate the editing and splicing of the serotonin receptor mRNA and affect serotonergic signaling.
Synaptic plasticity: modulation of the strength or efficacy of synaptic signaling
The above argument led to the suggestion that ncRNAs may be selected to enable rapid evolution and to enhance the performance of the nervous system. The unique miRNA milieu may help define and/or maintain the identity of each cell type in the brain. Somatic alterations caused by L1 insertions could, in theory, make every neuron genetically different and thus contribute to neuronal diversity. Furthermore, the distribution of L1 insertions is likely to be different in every brain, thereby contributing to the uniqueness of individuals within a population. Unlike most other cell types, neurons can extend their processes far away from their cell bodies. Moreover, each process, and even each synapse, of a neuron has its own identity because it interacts with its own microenvironment and probably stores specific information. Activity-dependent processes often require punctuated expression of genes at precise loci proximal to the site of activity. Neuronal activity-dependent mRNA translation is a crucial component of longterm synaptic plasticity (Kelleher et al. 2004 ). Many ncRNAs, with their ability to sequencespecifically bind to mRNAs, are ideal for the regulation of mRNA translation. Both the synthesis and degradation of RNAs are likely to require less time and energy than those of proteins. Thus, in theory, ncRNAs are adapted for a constantly changing microenvironment. Of course, another ideal mechanism is reversible modifications of proteins, such as phosphorylation and dephosphorylation, which indeed is a key component of synaptic plasticity (Dhavan & Tsai 2001 , Lisman et al. 2002 , Salter & Kalia 2004 , Sweatt 2004 , Winder & Sweatt 2001 . The catalytic prowess of proteins coupled with the expertise of ncRNAs for sequence-specific base complementarity could potentially maximize the functionality of the nervous system (see Figure 5 for an example of postulated roles of ncRNAs in neuronal differentiation and functioning). Such widespread roles of ncRNAs in the nervous system support Eddy's proposal that the ncRNAs we observe today are not simply ancient relics of the hypothesized "RNA World" at the origin of life. Instead, these "modern" ncRNAs are constantly evolving new roles to enhance the ability of organisms to adapt to the environment (Eddy 2001) .
